Toggle navigation
Regional
Industry
People
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Contact Us
Pharmaceuticals News
Source:
Google
Pharmaceuticals News
Rhythm Pharmaceuticals (RYTM) Could Be 15%
Rhythm Pharmaceuticals (RYTM) Could Be 15% Undervalued On Third Quarter Earnings Simply Wall St
Posted on 9 November 2026 | 10:27 pm
Acadia Pharmaceuticals Fell While Sales Rose
Acadia Pharmaceuticals Fell While Sales Rose Yahoo Finance
Posted on 9 November 2026 | 10:11 pm
Roche presents new data across
Roche presents new data across pharmaceuticals and diagnostics from its growing Alzheimer’s disease portfolio at CTAD 2026 The Manila Times
Posted on 9 November 2026 | 10:09 pm
Genentech and Roche Present New Data Across
Genentech and Roche Present New Data Across Pharmaceuticals and Diagnostics From Its Growing Alzheimer’s Disease Portfolio at CTAD 2026 Business Wire
Posted on 9 November 2026 | 10:00 pm
Form 144 AMYLYX PHARMACEUTICALS INC For: 10
Form 144 AMYLYX PHARMACEUTICALS INC For: 10 November By Investing.com Investing.com Canada
Posted on 9 November 2026 | 9:48 pm
Source:
Yahoo
Pharmaceuticals News
Review Assesses Unified ICH Guidelines for
Review Assesses Unified ICH Guidelines for Pharmaceutical Lifecycle Analytical Methods Bioengineer.org
Posted on 9 November 2026 | 9:28 pm
BioSpace 2027 Best Places to Work shines
BioSpace 2027 Best Places to Work shines light on most admired employers BioSpace
Posted on 9 November 2026 | 9:04 pm
“Pharmaceutical Security in Ohio:
“Pharmaceutical Security in Ohio: Exploring Public Options” event to be hosted Thursday, discussing how state-pharma could benefit all The Lantern
Posted on 9 November 2026 | 9:02 pm
Acadia Pharmaceuticals (ACAD) Stock Still
Acadia Pharmaceuticals (ACAD) Stock Still Looks Like A Bargain Today Yahoo Finance
Posted on 9 November 2026 | 8:55 pm
Acadia Pharmaceuticals Comments on Federal
Acadia Pharmaceuticals Comments on Federal Circuit Oral Argument in NUPLAZID® Formulation Patent Appeal Quantisnow
Posted on 9 November 2026 | 8:47 pm
Source:
Bing
Pharmaceuticals News
A Parkinson’s psychosis drug could have
A Parkinson’s psychosis drug could have patent protection until 2038—or 2030, depending on an appeal. Stock Titan
Posted on 9 November 2026 | 8:47 pm
Xenon Pharmaceuticals (XENE) Advances
Xenon Pharmaceuticals (XENE) Advances Azetukalner NDA Submission with Strong Clinical Data GuruFocus
Posted on 9 November 2026 | 8:08 pm
Missed Out On Rigel Pharmaceuticals' Run?
Missed Out On Rigel Pharmaceuticals' Run? Here's What Changed Simply Wall St
Posted on 9 November 2026 | 7:23 pm
Phio Pharmaceuticals Announces
Phio Pharmaceuticals Announces e-Presentation at American Society for Dermatologic Surgery (ASDS) Annual Meeting Akron Beacon Journal
Posted on 9 November 2026 | 7:21 pm
Xenon Pharmaceuticals Q3 Earnings Call
Xenon Pharmaceuticals Q3 Earnings Call Highlights Yahoo Finance
Posted on 9 November 2026 | 7:14 pm